CODI Post Congress Symposium Series – Supported by Novo Nordisk

DIABETES SYMPOSIUM – February 28, 2024

Moderator: Itamar Raz, Israel

18:30-18:40 – Residual Cardiovascular Risk in Type 2 Diabetes
Hilla Knobler, Israel

18:40-18:50 – The Cardio Renal Metabolic approach should we treat to prevent
Baruch Itzhak, Israel

18:50-19:00 – Brain Health & Diabetes
Tali Cukierman-Yaffe, Israel

19:00-19:15 – When it comes to Diabetes time is running out
Stefano Del Prato, Italy

19:15-19:45 – Panel discussion

OBESITY SYMPOSIUM – February 28, 2024

Moderator: Itamar Raz, Israel

20:30-20:45 Semaglutide 2.4mg for Obesity – what is the MoA?
Dror Dicker, Israel

20:45-21:00 Semaglutide 2.4mg for the treatment of Obesity- Beyond Weight Loss
Idit Dotan, Israel

21:00-21:30 Panel discussion

DIABETES SYMPOSIUM – Wednesday April 3, 2024

Moderator: Itamar Raz, Israel

20:00-20:15 – T1D clinics in the primary care set up
Dr. Eitan Roitman

20:15-20:30 – Emerging treatments in pre GDM
Dr. Yoel Toledano

20:30-21:00 – Q&A panel discussion